Quantcast

Latest Autoimmunity Stories

macrophages engulf dead cells
2014-09-08 02:00:50

Salk Institute Salk scientists identify how immune cells use two critical receptors to clear dead cells from the body, pointing the way to new autoimmune and cancer therapies. In most of the tissues of the body, specialized immune cells are entrusted with the task of engulfing the billions of dead cells that are generated every day. When these garbage disposals don’t do their job, dead cells and their waste products rapidly pile up, destroying healthy tissue and leading to autoimmune...

2014-09-08 08:31:19

SHM-XEL Platform Successfully Generates Novel Therapeutic Approach to Autoimmune Disease SAN DIEGO, Sept. 8, 2014 /PRNewswire/ -- AnaptysBio, Inc., a privately-held therapeutic antibody company, today announced that Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, has exercised its option to acquire a novel antibody program from AnaptysBio. Upon payment of an option exercise fee to...

2014-09-04 12:26:34

DIEPENBEEK, Belgium, September 4, 2014 /PRNewswire/ -- Scientists discover how to 'switch off' autoimmune diseases Apitope, the drug discovery and development company focused on disease-modifying treatments for patients with autoimmune and allergic diseases, announced today that Bristol University research led by Apitope Founder and CSO, Prof David Wraith, on its treatment approach to autoimmune diseases, such as Multiple Sclerosis (MS), has been published...

2014-09-01 04:20:02

A*STAR scientists find new targets for modulating antibody response Singapore, Sept 1, 2014 - (ACN Newswire) - Scientists from A*STAR's Bioprocessing Technology Institute (BTI) have uncovered the crucial role of two signalling molecules, DOK3 and SHP1, in the development and production of plasma cells. These discoveries, published in two prestigious journals PNAS and Nature Communications, advance the understanding of plasma cells and...

2014-08-27 12:30:09

Testing for the protein 14-3-3eta may improve the diagnosis of RA, including in early stages when treatment is most likely to improve outcomes MADISON, N.J., Aug. 27, 2014 /PRNewswire/ -- A novel biomarker for rheumatoid arthritis (RA) has significant potential to help physicians better identify early-stage disease, when treatment can often arrest further disease progression and disability, according to a new study in The Journal of Rheumatology....

2014-08-27 08:27:25

ORLANDO, Fla, Aug. 27, 2014 /PRNewswire/ -- TNI BioTech Inc. (OTCQB: TNIB), ("we" or the "Company") a biotechnology company pioneering the manufacturing and marketing of innovative therapies for autoimmune diseases in emerging nations, today announced it had received payment and will make its first shipments of Lodonal(®) to the Republic of Panama and The Republic of Malawi in conjunction with our marketing partner, The Brewer Group, Inc. Commenting on the initial shipments, Noreen...

2014-08-26 12:28:02

ANN ARBOR, Mich., Aug. 26, 2014 /PRNewswire/ -- Lycera Corp., a biopharmaceutical company pioneering the development of breakthrough oral medicines to treat autoimmune disease and cancer based on the science of immune modulation, today announced the appointment of Harinder Singh, Ph.D., as chair of the company's scientific advisory board. Dr. Singh will lead the board's efforts to provide guidance and insight to advance Lycera's multiple ongoing research programs and pipeline of...

astronaut immune system
2014-08-19 04:06:43

redOrbit Staff & Wire Reports - Your Universe Online Newly discovered changes to the human immune system that occur during spaceflight could force NASA to address potential health concerns in future six-month to one-year-long manned missions to nearby asteroids or Mars. Writing in a recent edition of the Journal of Interferon & Cytokine Research, scientists involved with a pair of NASA collaborative investigations suggest that something as innocent as the common cold or a case...

Scientists Find Control Signal For Immune System That Could Help Treat Autoimmune Diseases And Cancer
2014-08-18 03:19:20

Salk Institute When faced with pathogens, the immune system summons a swarm of cells made up of soldiers and peacekeepers. The peacekeeping cells tell the soldier cells to halt fighting when invaders are cleared. Without this cease-fire signal, the soldiers, known as killer T cells, continue their frenzied attack and turn on the body, causing inflammation and autoimmune disorders such as allergies, asthma, rheumatoid arthritis, multiple sclerosis and type 1 diabetes. Now, scientists at...

2014-08-14 12:28:37

Expert from the Largest Scleroderma Specialty Center in the U.S. at Johns Hopkins will Provide Insight to Help Patients, Physicians and Caregivers. SAN FRANCISCO, Aug. 14, 2014 /PRNewswire-USNewswire/ -- Dr. Francisco Boin of the Scleroderma Center at The Johns Hopkins University School of Medicine, one of the largest scleroderma specialty clinics in the world, will host a live, free webinar on Thursday, August 21, 2014 at 1:00 p.m. EDT. The webinar is presented by the Scleroderma...


Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.